Open AccessCombined treatment with radiotherapy, chemotherapy and avelumab results in regression of metastatic Merkel cell carcinoma and improvement of associated Lambert‑Eaton myasthenic syndrome: A case report
Author(s) -
Caroline Green,
Martin Isaksson Mettävainio,
Christina Kjellman,
Torbjörn Ramqvist,
Tina Dalianis,
Pernilla Israelsson,
David Lindquist
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13513
Subject(s) - merkel cell carcinoma , medicine , merkel cell , radiation therapy , chemotherapy , malignancy , avelumab , lambert eaton myasthenic syndrome , carcinoma , oncology , cancer , immunotherapy , myasthenia gravis , pembrolizumab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom